Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts
Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Amgen's Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source link
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
Could Scientist Find Drug to Treat His Own Disease?
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
Efforts to Spotlight Private Equity's Healthcare Stakes Struggle for Traction
Congress and regulatory agencies have made scant headway in requiring medical companies to reveal owners. Source link
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.